According to NEC, that'll let them "cut dissipation for digital consumer electronics in the standby mode to just a few percent of what it is now, " and at no expense of convenience.
Schering-Plough is now in turnaround mode, still recovering from a period in which its drug sales were cut back considerably by patent expirations and competition from other big pharmaceutical companies.